.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Chinese Patent Office
Harvard Business School
Johnson and Johnson
Cipla
Cerilliant
McKinsey
Express Scripts
Healthtrust
Colorcon

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070655

« Back to Dashboard

NDA 070655 describes FUROSEMIDE, which is a drug marketed by Abraxis Pharm, Accord Hlthcare, Amneal Pharms Co, Astrazeneca, Baxter Hlthcare Corp, Emcure Pharms Ltd, Fresenius Kabi Usa, Hospira, Igi Labs Inc, Intl Medication, Luitpold, Marsam Pharms Llc, Smith And Nephew, Warner Chilcott, Watson Labs, West-ward Pharms Int, Wockhardt, Wyeth Ayerst, Dava Pharms Inc, Ipca Labs Ltd, Ivax Sub Teva Pharms, Kalapharm, Leading Pharma Llc, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, and Watson Labs Teva, and is included in fifty-seven NDAs. It is available from sixty-one suppliers. Additional details are available on the FUROSEMIDE profile page.

The generic ingredient in FUROSEMIDE is furosemide. There are twenty-one drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the furosemide profile page.

Summary for 070655

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 070655

Medical Subject Heading (MeSH) Categories for 070655

Suppliers and Packaging for NDA: 070655

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FUROSEMIDE furosemide SOLUTION;ORAL 070655 ANDA Morton Grove Pharmaceuticals, Inc. 60432-613 60432-613-60 60 mL in 1 BOTTLE, DROPPER (60432-613-60)
FUROSEMIDE furosemide SOLUTION;ORAL 070655 ANDA Morton Grove Pharmaceuticals, Inc. 60432-613 60432-613-04 120 mL in 1 BOTTLE, WITH APPLICATOR (60432-613-04)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength10MG/ML
Approval Date:Oct 2, 1987TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
McKinsey
Daiichi Sankyo
Accenture
US Department of Justice
US Army
Harvard Business School
Dow
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot